ANAYLISIS OF NOVEL PROSTATE CANCER BIOMARKERS AND THEIR PREDICTIVE UTILITY IN AN ACTIVE SURVEILLANCE PROTOCAOL
$1,404,000FY2011Department of DefenseDOD
The General Hospital Corporation
Investigators
View source on USAspending →ANAYLISIS OF NOVEL PROSTATE CANCER BIOMARKERS AND THEIR PREDICTIVE UTILITY IN AN ACTIVE SURVEILLANCE PROTOCAOL · GrantIndex